Abstract
Introduction
Central neurocytoma (CN) is a very rare neuronal neoplasm. The clinical implications of the potential prognostic factors for these lesions, including tumor atypia, have therefore not been clarified.
Methods
Forty CN patients were enrolled and reclassified as typical or atypical in accordance with an MIB-1 labeling index (LI) of above and below 2%.
Results
We classified our retrospective study cohort as 21 (52.5%) typical and 19 (47.5%) atypical CN cases. No significant differences were found in terms of sex, mean age, mean tumor size or tumor location between these groups. Recurrences occurred in 2 (9.5%) typical and 6 (33.3%) atypical cases. The typical CN 2-,3- and 5-year PFS rates were 100%, 100%, 92.3%, and those for the atypical group were 93.8%, 78.1%, 65.1%, respectively (p = 0.02). The PFS rates did not statistically differ by treatment modality (gross total resection alone, subtotal resection (STR) alone and STR plus radiation therapy (RT) or radiosurgery (RS)) either in the whole cohort (p = 0.75) or in the typical CN and atypical CN subgroups (p = 0.45 and 0.98, respectively). An atypical histology was the only prognostic indicator of recurrence by univariate analysis (hazard ratio: 5.40, p = 0.04).
Conclusions
An atypical lesion (MIB-LI > 2%) is an important prognostic indicator in CN. The clinical implications of the extent of resection for CN patients are still debatable. The use of STR plus RT or RS may be a viable treatment strategy for CN but different therapeutic and follow-up approaches for atypical CN will be needed.
Similar content being viewed by others
References
Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, Toga M (1982) Central neurocytoma: an electron-microscopic study of two cases. Acta Neuropathol 56:151–156
Hassoun J, Söylemezoglu F, Gambarelli D, Figarella-Branger D, Ammon Kv, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3:297–306
Wang M, Zhou P, Zhang S, Liu X, Lv L, Wang Z, Ye F, Wang X, Jiang S (2018) Clinical feuatures, treatment, and long-term outcomes of central neurocytoma: a 20-year experience at a single center. World Neurosurg 109:259–266
Mackenzie IRA (1999) Central neurocytoma histologic atypia, proliferation potential, and clinical outcome. Cancer 85:1606–1610
Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neuro-Oncol 66:377–384
Soylemezoglu F, Scheithauer BW, Esteve J, Kleihues P (1997) Atypical central neurocytoma. J Neuropathol Exp Neurol 56:551–556
Yasargil MG, Ammo KV, Deimling AV, Vanis AVA, Wichmann W, Wiestler OD (1992) Central neurocytoma: histopathological variants and therapeutic approaches. J Neurosurg 76:32–37
Dutta SW, Kaleem TA, Muller DA, Peterson J, Harrell AC, Quinones-Hinojosa A, Trifiletti DM (2018) Central neurocytoma: clinical characteristics, patterns of care, and survival. J Clin Neurosci 53:106–111
Ahmad Z, Din NU, Memon A, Tariq MU, Idrees R, Hasan S (2016) Central, extraventricular and atypical neurocytomas: a clinicopathologic study of 35 cases from Pakistan plus a detailed review of the published literature. Asian Pac J Cancer Prev 17:1565–1570
Rades D, Schild SE, Fehlauer F (2004) Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62:987–989
Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK, Tihan T, Barnes M, Mueller S, Butowski NA, Clarke JL, Chang SM, McDermott MM, Prados MD, Berger MS, Haas-Kogan DA (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neuro-Oncol 126:193–200
Hallock A, Hamilton B, Ang LC, Tay KY, Meygesi JF, Fisher BJ, Watling CJ, Macdonald DR, Bauman GS (2011) Neurocytomas: long-term experience of a single institution. Neuro-Oncology 13:943–949
Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neuro-Oncol 77:305–309
Vasiljevic A, Francois P, Loundou A, Fe`vre-Montange M, Jouvet A, Roche P-H, Figarella-Branger D (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36:220–227
Leenstra JL, Rodriguez FJ, Frechette CM, Giannini C, Stafford SL, Pollock BE, Schild SE, Scheithauer BW, Jenkins RB, Buckner JC, Brown PD (2007) Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67:1145–1154
Garcia RM, Ivan ME, Oh T, Baranic I, Parsa AT (2014) Intraventricular neurocytomas: a systematic review of stereotactic radiosurgery and fractionated conventional radiotherapy for residual or recurrent tumors. Clin Neurol Neurosurg 117:55–64
Anderson R, Ghatan S, Feldstein N (2003) Surgical approaches to tumors of the lateral ventricle. Neurosurg Clin N Am 14:509–525
Milligan BD, Meyer FB (2010) Morbidity of transcallosal and transcortical approaches to lesions in and around the lateral and third ventricles: a single-institution experience. Neurosurgery 67:1483–1496
Park ES, Cho YH, Kim JH, Kim SJ, Khang SK, Kim CJ (2012) Frontal transcortical approach in 12 central neurocytomas. Acta Neurochir 154:1961–1971
Chen Y-D, Li W-B, Feng J, Qiu X-G (2014) Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma. Radiat Oncol 9:242
Paek SH, Han J-H, Kim JW, Park C-K, Jung H-W, Park S-H, Kim IH, Kim DG (2008) Long-term outcome of conventional radiation therapy for central neurocytoma. J Neuro-Oncol 90:25–30
Karlsson B, Guo W-Y, Kejia T, Dinesh N, Pan DH-C, Jokura H, Kawagishi J, Eck ATCJv, Horstmann GA, Yeo TT, Yamamoto M (2012) Gamma Knife surgery for central neurocytomas. J Neurosurg 117:96–101
Bui TT, Lagman C, Chung LK, Tenn S, Lee P, Chin RK, Kaprealian T, Yang I (2017) Systematic analysis of clinical outcomes following stereotactic radiosurgery for central neurocytoma. Brain Tumor Res Treat 5:10–11
Kim JW, Kim DG, Chung H-T, Choi SH, Han JH, Park C-K, Kim C-Y, Paek SH, Jung H-W (2013) Radiosurgery for central neurocytoma: long-term outcome and failure pattern. J Neuro-Oncol 115:505–511
Acknowledgements
We thank the referring physicians, our institutional neuroradiologists and pathologists.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests in relation to this study.
Rights and permissions
About this article
Cite this article
Byun, J., Hong, S.H., Yoon, M.J. et al. Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience. J Neurooncol 140, 669–677 (2018). https://doi.org/10.1007/s11060-018-2997-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-018-2997-z